kuvura kanseri ntoya

Kuvura kanseri ntoya . Ubuvuzi rusange burimo kubaga, imivugo, imiti ya chimiotherapie, imiti igenewe, hamwe na impfuya, akenshi bikoreshwa muburyo bwo guhuza. Aka gatabo karambuye muburyo burambuye, kugufasha gusobanukirwa nibishoboka no gufata ibyemezo byuzuye mugisha inama yubuvuzi.ubwumvikane butari buri kare (NSCLC) NCSLC ni iki muri NSCLC?Kanseri idahwitse . Ni ijambo umutaka ririmo subtypes nyinshi, ibintu bikunze kugaragara Adencarcinoma, karcinoma yakagari, hamwe na karcinoma nini ya karcinoma.nsclc ni ngombwa kugirango igena uburyo bwiza bwo kuvura. Icyiciro kigenwa nubunini n'ahantu h'ibibyimba, haba ikwirakwiriye kuri lymph node yegeranye, kandi niba byanze bikunze inzego za kure. Amahitamo ya Nclcsurger Intego ni ugukuraho ikibyimba hamwe na lymph imwe hafi ya lymph ishobora kuba irimo selile za kanseri. Lobectomy: Gukuraho lobe yose y'ibihaha. Pnemonectombe: Gukuraho ibihaha byose. Wedge Gukuraho igice gito, cya Wedge. Segmenstectomy: Gukuraho igice cyibihaha, binini kuruta ubusakubwo ariko buke kuruta thivectomity.Icyitonderwa: Kubaga ntibishobora kuba amahitamo kubarwayi ba NSCLC bateye imbere cyangwa abafite ubundi buzima bwo kubaga. Kuramya kwamamaza ibicuruzwa bikoresha imivugo ikoresha imirasire yingufu zo kwica kanseri. Irashobora gukoreshwa mugufata NSCLC muburyo butandukanye: Kuvura imivugo yo hanze ya Beam (EBrt): Imirasire iterwa nimashini hanze yumubiri. Umuyoboro wa Stereotactic Kuvura imivugo (SBRT): Uburyo busobanutse neza bwa EBRT butanga igipimo kinini cyimirasire ahantu hato. Akenshi ikoreshwa muri kanseri yimyanda yo hambere mugihe kubagwa bidashoboka. Brachytherapy: Ibikoresho bya radio byashyizwe mu buryo butaziguye cyangwa hafi ya Tumor. Kuvura imivugo birashobora gukoreshwa wenyine cyangwa ufatanije nubundi buvuzi, nka chimiotherapie. Twebwe Shandong Baofa Kanseri Ikigo cyubushakashatsi Sobanukirwa n'akamaro ko guhuza imiti y'ibisubizo byiza. Baofa numuyobozi witayeho kanseri.HomotherapifheTherapie akoresha ibiyobyabwenge kugirango ace kanseri kumubiri. Bikunze gukoreshwa gufata NSCLC yateye imbere cyangwa gukumira kanseri yo gusubiramo nyuma yo kubagwa. Common chemotherapy drugs for NSCLC include: Cisplatin Carboplatin Pemetrexed Docetaxel PaclitaxelChemotherapy is typically given in cycles, with periods of treatment followed by periods of rest. Ingaruka zuruhande zirashobora gutandukana bitewe nibiyobyabwenge byakoreshejwe hamwe nabarwayi kugiti cyabo.Gukoresha imiti ikoresha ibiyobyabwenge byihariye molekile zihariye zigira uruhare mugutezirwa ka kanseri no kubaho. Iyi miti akenshi irakorwa neza kandi ifite ingaruka nkeya kuruta chimiotherapie. Ubuvuzi bugamije mubisanzwe kubarwayi bafite ihinduka ryihariye. Intego rusange zirimo: Egfr: Imikurire yimikurire ya reseptor Alk: Anaplastic lymphoma kinase Ros1: Ros1 Proto-Oncogene Kwakira Tyrosine Kinase BRAF: B-raf proto-ogcogene, Serine / Tontnonine Kinase NTRK: Inzozi za Neurotroproc Tyroptor Kinaseer ya Merapy Ibiyobyabwenge Byakoreshejwe muri NSCLC birimo: Gefitinib (Igilova) Osimetero) Ositinib (Xalkolif) Ositinib (Zocenso) Ositinib (Zocenso) Ositinib (Zykadia) OSITICIB (Zykadia) Ositinib (Zykadia) Olecena) Mbere yo gutangira kuvura, Abarwayi mubisanzwe bagerageza genetike kugirango bamenye niba bafite umwicanyi .ImMunotherapimMunotherapie akoresha ibiyobyabwenge kugirango afashe kanseri yumubiri kurwanya kanseri yumubiri. Iyi miti irashobora guhagarika poroteyine iribuza sisitemu yumubiri kubangamira kanseri. Ibiyobyabwenge bisanzwe mpLC birimo: PembrorZumab (GAMELRUDAB) NIVOLUMAB (OPDIVO) ATTOMOTHERAB (TURTOMAB) Durvantritherapy irashobora gukoreshwa wenyine cyangwa guhuza na chimiotherapie cyangwa ubundi buryo. Ingaruka zuruhande zishobora kubamo umunaniro, uruhu rutera inzitizi, no gutwika inzego zitandukanye.nsclc kuvura ukoresheje stagestage i nsclcsury ikunze kwivuza i NCCLC. SBRT irashobora gutekerezwa mugihe umurwayi atari umukandida utanga umukandida.tage II NSCLCREATMENT yicyiciro cya NSCLC ubusanzwe bikubiyemo kubaga bikurikirwa na chimiotherapie. Umuyoboro w'imirasire ushobora kandi gukoreshwa.Stage III NSCLCREATMENT III NSCLC iragoye kandi irashobora guhuza no kubaga, no kuvura imivugo. Impimupfumu irashobora kandi gukoreshwa nyuma ya chemoration mubihe bimwe na bimwe.haza IV NSCLCREATMENT Igenamize rya Kurwanya Kanseri no kugabanya ibimenyetso. Amahitamo arashobora kuba arimo chemitherapie, imiti igenewe, imyumbavuya, nubuvuzi bwimirasire. Guhitamo kwivuza biterwa nibiranga kanseri hamwe nibigeragezo byubuzima rusange byubuzima. Ubushakashatsi bwubushakashatsi bugerageza uburyo bushya bwo kuvura kanseri. Abarwayi hamwe na NSCLC barashobora kwemererwa kwitabira ibigeragezo byubuvuzi. Vugana na muganga wawe kugirango umenye byinshi kubyerekeye ibigeragezo byubuvuzi niba bakubereye. Shandong Baofa Kanseri Ikigo cyubushakashatsi Kwiyemeza gukora ubushakashatsi bivuze ko tuguma ku nkombe z'uburyo bushya bwo kuvura, rimwe na rimwe binyuze mu mafarasi. Ibyemezo byo kuvura ubuvuzi. Ibintu ugomba gusuzuma birimo urwego na subtype ya kanseri, ubuzima rusange bwumurwayi, nibyo bakunda. Ntutindiganye kubaza ibibazo kandi ushake igitekerezo cya kabiri iyo bikenewe.GomburbalEsVoval-igipimo cyibipimo bya NSCLC byanze bitewe na kanseri, ubuvuzi bwakiriwe, nibindi bintu. Kumenya hakiri kare no kuvura birashobora kunoza amahirwe yo kubaho. Icyiciro cyimyaka 5 yo kubaho igipimo cyicyiciro cya I 68-92% Icyiciro II 53-60% Icyiciro III 13-36% Icyiciro IV munsi ya 10% * Inkomoko: Sosiyete ya kanseri y'Abanyamerika (www.cancer.org) Kubana na NSCLCLIVIving hamwe na NSCLC birashobora kugorana, ariko hariho ibikoresho byinshi biboneka kugirango bifashe abarwayi nimiryango yabo. Ibi bikoresho birimo amatsinda ashigikira, serivisi zubujyanama, hamwe na gahunda zifasha mu mafaranga.